Biodesix to present at cowen's 42nd annual healthcare conference

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced scott hutton, chief executive officer of biodesix, will present at cowen's 42nd annual healthcare conference being held virtually march 7-9, 2022. cowen's 42nd annual healthcare conference date: tuesday, march 8, 2022 time: 2:50 pm et the presentation will be webcast live and available for replay under “news & events” in the investo
BDSX Ratings Summary
BDSX Quant Ranking